Dataset Information

Characterization of Equine Platelet Lysate for Nebulization in the Horse

ABSTRACT: Platelet lysate (PL) demonstrates antimicrobial and anti-inflammatory properties and may offer potential for treatment of bacterial pneumonia in horses. It remains unknown whether nebulization represents a suitable method of administration of PL in horses. This study characterized particle size and flow rate of pooled equine PL nebulized using an equine-specific nebulizer (Flexivent). Protein composition and antimicrobial activity were compared before and after nebulization. Protein composition was evaluated according to growth factor, antimicrobial peptide and cytokine concentrations and proteomic analysis. To evaluate antimicrobial activity, bacterial growth inhibition [maximum growth (µmax); carrying capacity (K)] were determined for E.coli, Streptococcus equi subsp zooepidemicus and Rhodococcus equi (WT and MDR) using pre- and post-nebulized PL concentrations of 50%. Flow rate and median particle size were 0.8 ml/min and 4.991 µm with 52% of particles ≤ 5 µm. Cytokine, growth factor, and antimicrobial peptide concentrations and proteomic profiles were similar pre- and post-nebulization. For all bacteria, nebulization did not alter effect of PL on growth parameters. Negative effects of PL treatments on K were noted for S. zooepidemicus (p= 0.009 all) compared to BHI. No effect of PL was observed on µmax for S.zooepidemicus and on K and µmax for E.coli. For R. equi (WT and MDR), K and µ were positively affected by PL treatments (p≤ 0.05). We concluded that nebulization does not appear to meaningfully impact PL bacterial growth inhibition or protein composition. Further research is recommended to better characterize PL antimicrobial activity against clinically relevant pathogens and suitability for nebulization in horses.

ORGANISM(S): Equus Caballus

SUBMITTER: Kara Lascola

PROVIDER: PXD055023 | JPOST Repository | Thu Dec 26 00:00:00 GMT 2024

REPOSITORIES: jPOST

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	23-118-Lascola-Post-A1-120.raw	Raw
	23-118-Lascola-Post-B1-120.raw	Raw
	23-118-Lascola-Post-C1-120.raw	Raw
	23-118-Lascola-Pre-120_20231002154139.raw	Raw
	23-118-Lascola-platelet-lysate-Byonic-quan.mzML	Mzml

Items per page:

1 - 5 of 13

Publications

Pilot study characterizing a single pooled preparation of equine platelet lysate for nebulization in the horse.

Egli Patricia P Boone Lindsey L Huber Laura L Higgins Courtney C Gaonkar Pankaj P PP Arrington Justine J Naskou Maria C MC Peroni John J Gordon Julie J Lascola Kara M KM

Frontiers in veterinary science 20241212

<h4>Introduction</h4>Platelet lysate (PL) demonstrates antimicrobial and anti-inflammatory properties offering potential for treatment of bacterial pneumonia in horses. It remains unknown whether nebulization is suitable for PL administration in horses. This pilot study characterized particle size and flow rate of pooled equine PL (single preparation) nebulized using an equine-specific nebulizer (Flexivent<sup>®</sup>).<h4>Methods</h4>Protein composition and antimicrobial activity were compared ...[more]

PMID: 39726585

Similar Datasets

Project description:Growing evidence supports the importance of extracellular vesicle (EV) as mediators of communication in pathological processes, including those underlying respiratory disease. However, establishing methods for isolating and characterizing EVs remains challenging, particularly for respiratory samples. This study set out to address this challenge by comparing different EV isolation methods and evaluating their impacts on EV yield, markers of purity, and proteomic signatures, utilizing equine/horse bronchoalveolar lavage samples. Horses are an excellent translational animal model for respiratory studies due to similarities with human immune responses, shared environmental exposures, and naturally occurring respiratory diseases including asthma. Further, horses are long-lived large animals that allow for longitudinal sample collection, and provide large sample volume and cell yield, which are particularly useful since EV research is commonly limited by low sample yields. Here, EVs were isolated from horse bronchoalveolar lavage fluid (BALF) using four different methods (ultracentrifugation, microcentrifugation, and two sizes of size exclusion chromatography columns) and characterized by measuring particle counts, EV purity, total protein yield, and proteomic cargo, with a specific focus on vesicle surface marker expression potentially informing cell type of origin. We found that size exclusion chromatography yielded the highest particle counts, greatest EV purity markers and elevated vesicle surface marker expression. Overall proteomic profiles differed across isolation methods, with size exclusion chromatography clustering separately from centrifugation. Taken together, our results demonstrate that different isolation methods impact characteristics of EVs, notably that size exclusion chromatography, compared to centrifugation methods, resulted in higher EV purity and better characterized proteomic diversity, including information on EV cell of origin. This is the first study to characterize proteomic profiles of EVs following different isolation methods using equine BALF. The results of this study will pave the way for future studies using equine samples as a model to characterize human respiratory tract EVs.